The Future of Non-Viral Delivery: Niche Player or Gene Therapy Cornerstone?Published: February 4, 2019
VECTOR CHANNEL: NON-VIRAL DELIVERY METHODS
Lynn Zechiedrich is the Kyle and Josephine Morrow Chair and Professor in Molecular Virology and Microbiology at Baylor College of Medicine. She developed minivectors to study DNA, the enzymes that act on DNA, and the antibiotic and anticancer drugs that inhibit these enzymes. Minivectors also proved to be excellent gene therapy delivery vectors. Among other honors, she won a New Investigator Award from the Burroughs Wellcome Fund, a Curtis Hankamer Research Award, and funding from the Human Frontier Science Program. She is a Fellow of the National Academy of Inventors. She was Baylor College of Medicine’s BRASS Mentor of the Year in 2013. She holds two issued US patents and three issued foreign patents that are licensed to Twister Biotech, Inc., a company she founded in 2011, and has multiple patents pending. She has published more than 60 articles and book chapters and given over 170 invited talks. She served on numerous grant review committees, reviews for 40 different peer-reviewed journals, ranging from mathematics and physics to microbiology and gene therapy, and serves on multiple editorial boards.DOI: 10.18609/cgti.2019.001
Citation: Cell Gene Therapy Insights 2019; 5(S1), 1-7.